T46.5X2A Poisoning by other antihypertensive drugs, intentional self-harm, initial encounter

Name of the Condition

• Poisoning by other antihypertensive drugs, intentional self-harm, initial encounter
• ICD-10 Code: T46.5X2A

Summary

This code describes intentional self-harm involving poisoning by antihypertensive medications during an initial encounter. It applies when a patient deliberately ingests these drugs to cause harm, requiring immediate clinical assessment and intervention. The condition reflects a serious overdose scenario with potential for significant physiological effects.

Causes

Intentional self-harm poisoning occurs when a patient purposefully takes an excessive amount of antihypertensive drugs. This may involve deliberate ingestion of multiple doses or entire prescriptions, often driven by psychological distress or suicidal intent. The underlying cause is the intentional misuse of medications for self-inflicted harm.

Risk Factors

• History of mental health conditions (e.g., depression, anxiety)
• Prior suicide attempts or ideation
• Access to medications without supervision
• Social isolation or acute life stressors
• Substance use disorders

Symptoms

• Severe dizziness, syncope, or loss of consciousness
• Profound hypotension (low blood pressure)
• Nausea, vomiting, or abdominal pain
• Bradycardia (slow heart rate) or arrhythmias
• Confusion, lethargy, or coma
• Respiratory depression in severe cases

Diagnosis

Diagnosis requires confirmation of intentional self-harm and antihypertensive drug exposure. Clinical evaluation includes patient history, physical exam, and toxicology screening. Documentation must specify the intent (intentional self-harm) and encounter type (initial). Laboratory tests may assess drug levels and organ function.

Treatment Options

Treatment focuses on stabilizing the patient, managing toxicity, and addressing psychological needs. Interventions may include activated charcoal, intravenous fluids, vasopressors for hypotension, and cardiac monitoring. Psychiatric evaluation and crisis intervention are critical components of care.

Prognosis and Follow-Up

Prognosis depends on the dose ingested, time to treatment, and underlying health. Close monitoring is essential during the initial encounter. Follow-up includes psychiatric assessment, medication reconciliation, and safety planning to prevent recurrence.

Complications

• Refractory hypotension requiring intensive care
• Cardiac arrhythmias or myocardial infarction
• Acute kidney injury from hypoperfusion
• Neurological damage (e.g., seizures, coma)
• Psychological sequelae (e.g., PTSD, depression)

Lifestyle & Prevention

• Secure storage of medications to limit access
• Regular mental health screenings for at-risk individuals
• Education on safe medication handling
• Support systems for patients with suicidal ideation
• Collaboration with mental health providers for ongoing care

When to Seek Professional Help

Seek immediate medical attention if self-harm is suspected or if symptoms like severe dizziness, fainting, or confusion occur after medication ingestion. Emergency services should be contacted for any intentional overdose.

Tips for Medical Coders

Document intent (intentional self-harm) and encounter type (initial) clearly. Code T46.5X2A is specific to initial encounters; subsequent care uses different encounter codes. Ensure toxicology results and clinical notes support the diagnosis.